Characterization and targeting of phosphatidylinositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in renal cell cancer
Aymen Elfiky(Dana-Farber Cancer Institute), Harriet M. Kluger(Yale Cancer Center)
Cited by 51
Related Papers
Phosphatidylinositol-3-Kinase as a Therapeutic Target in Melanoma
|Clinical Cancer Research|2009|72